Which stocks to buy, hold or sell today? As Dalal Street enters the May 9 session, here's a look at what brokerages make of some of the key stocks in focus.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Stocks like Pidilite Industries, Kansai Nerolac, Mahanagar Gas Limited, Exide Industries, UPL, Sun Pharma, and other shares are on their radar today.

Do you have any of these stocks in your portfolio?

Check out the full list of what brokerages recommend, including Pidilite Industries, Kansai Nerolac, Mahanagar Gas Limited, Exide Industries, UPL, Sun Pharma, and other stocks:

Pidilite Industries

Global brokerages are skeptical on Pidilite Industries after lower-than-estimated earnings of fevicol maker in the March quarter of the financial year 2022-23. Macquarie maintained an ‘underperform’, rating, while JP Morgan has an ‘underweight’ stance on the stock.

Amid competitive pressures from paint players, the company pointing to near-term uncertainty, Macquarie said, adding that it remains concerned about FY24/25 EPS.

 

Brokerage Rating Price Target
Macquarie Underperform Rs 2,000
JP Morgan Underweight Rs 2,150

 

Mahanagar Gas

 

Despite good Q4 earnings, the brokerages are divided on Mahanagar Gas shares as Macquarie maintained a ‘neutral’ call, while retains a ‘hold’ call on the stock.

 

Brokerage Rating Price Target
Macquarie Neutral Rs 925
Jefferies Hold Rs 1,100

Kansai Nerolac

Brokerages are divided on Kansai Nerolac as Macquarie has a ‘neutral’ rating, while Morgan Stanley retains an ‘underperform’ call and Nomura has a ‘buy’ stance on the stock.

 

Brokerage Rating Price Target
Macquarie Neutral Rs 415
Morgan Stanley Underperform Rs 322
Nomura Buy Rs 575

Exide Industries

Brokerages are bullish on Exide Industries shares despite missing estimates, Citi gives a ‘buy’ call, while JP Morgan maintained an ‘overweight’ rating on the stock.

 

Brokerage Rating Price Target
Citi Buy Cut to Rs 240 from Rs 265
JP Morgan Overweight Rs 225

UPL

Jefferies maintained a ‘buy’ stance on UPL with a revised target of Rs 925 from Rs 905 apiece. The company missed Q4 estimates due to sharp operating margins decline.

Catch the latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.